← GILEAD SCIENCES, INC.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $30.4b |
$26.1b
-14.09%
|
$22.1b
-15.24%
|
$22.4b
+1.46%
|
$24.7b
+9.98%
|
$27.3b
+10.60%
|
$27.3b
-0.09%
|
$27.1b
-0.60%
|
$28.8b
+6.04%
|
$29.4b
+2.40%
|
$30.5b
+3.44%
|
|
| Cost of Revenue | $4.3b |
$4.4b
+2.58%
|
$4.9b
+11.03%
|
$4.7b
-3.67%
|
$4.6b
-2.20%
|
$6.6b
+44.38%
|
$5.7b
-14.30%
|
$6.5b
+14.87%
|
$6.3b
-3.80%
|
$6.2b
-0.27%
|
$6.2b
-0.29%
|
|
| Cost of goods sold | $4.3b |
$4.4b
+2.58%
|
$4.9b
+11.03%
|
$4.7b
-3.67%
|
$4.6b
-2.20%
|
$6.6b
+44.38%
|
$5.7b
-14.30%
|
$6.5b
+14.87%
|
$6.3b
-3.80%
|
$6.2b
-0.27%
|
$6.2b
-0.29%
|
|
| Gross Profit (Calculated) | $26.1b |
$21.7b
-16.81%
|
$17.3b
-20.53%
|
$17.8b
+2.89%
|
$20.1b
+13.18%
|
$20.7b
+2.92%
|
$21.6b
+4.44%
|
$20.6b
-4.65%
|
$22.5b
+9.14%
|
$23.2b
+3.14%
|
— | |
| Acquired in-process research and development expenses | — | — | $1.1b | $5.1b | $5.9b | $177.0m | $944.0m | $1.2b | $4.7b | $1.0b | — | |
| In-process research and development impairments | — | — | — | — | $0 | $0 | $2.7b | $50.0m | $4.2b | $590.0m | — | |
| Research and Development Expense | $5.1b | $3.7b | $5.0b | $9.1b | $5.0b | $5.4b | $5.0b | $5.7b | $5.9b | $5.8b | $6.1b | |
| Selling, General and Administrative Expense | $3.4b | $3.9b | $4.1b | $4.4b | $5.2b | $5.2b | $5.7b | $6.1b | $6.1b | $5.8b | $6.5b | |
| Amortization of Intangible Assets | — | — | — | — | — | — | $1.8b | $2.3b | $2.4b | $2.4b | — | |
| Operating Lease, Expense | — | — | — | $162.0m | $171.0m | $156.0m | $162.0m | $165.0m | $163.0m | $169.0m | — | |
| Operating expenses: | ||||||||||||
| Operating Income (Loss) | $17.6b |
$14.1b
-19.90%
|
$8.2b
-41.94%
|
$4.3b
-47.72%
|
$4.1b
-5.04%
|
$9.9b
+143.63%
|
$7.3b
-26.09%
|
$7.6b
+3.75%
|
$1.7b
-78.15%
|
$10.0b
+503.01%
|
$11.7b
+16.91%
|
|
| Interest Expense | $964.0m | $1.1b | $1.1b | $995.0m | $984.0m | $1.0b | $935.0m | $944.0m | $977.0m | $1.0b | $998.0m | |
| Fair Value, Option, Changes in Fair Value, Gain (Loss) | ($128.0m) | — | — | — | — | — | — | — | — | — | — | |
| Other Nonoperating Income (Expense) | — | — | — | — | — | — | — | — | ($2.0m) | ($1.0m) | — | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | $7.6b | $8.1b | $7.1b | $4.1b | $2.5b | $8.6b | $4.4b | $5.5b | ($876.0m) | $8.3b | ($2.0b) | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | — | — | $7.8b | $5.2b | $1.7b | $8.3b | $5.8b | $6.9b | $690.0m | $9.8b | ($2.0b) | |
| Income Tax Expense (Benefit) | $3.6b | $8.9b | $2.3b | ($204.0m) | $1.6b | $2.1b | $1.2b | $1.2b | $211.0m | $1.3b | $1.3b | |
| Net Income (Loss) Attributable to Parent | $13.5b |
$4.6b
-65.72%
|
$5.5b
+17.87%
|
$5.4b
-1.26%
|
$123.0m
-97.72%
|
$6.2b
+4960.98%
|
$4.6b
-26.23%
|
$5.7b
+23.37%
|
$480.0m
-91.53%
|
$8.5b
+1672.92%
|
($3.2b)
-138.07%
|
|
| Net Income (Loss) Attributable to Noncontrolling Interest | ($13.0m) | $16.0m | $5.0m | ($22.0m) | ($34.0m) | ($24.0m) | ($26.0m) | ($52.0m) | $0 | $0 | ($3.2b) | |
| Net loss attributable to noncontrolling interest | ($13.0m) | $16.0m | $5.0m | ($22.0m) | ($34.0m) | $24.0m | $26.0m | $52.0m | $0 | $0 | — | |
| Earnings Per Share, Basic | $10.08 | $3.54 | $4.20 | $4.24 | $0.10 | $4.96 | $3.66 | $4.54 | $0.38 | $6.84 | ($2.61) | |
| Earnings Per Share, Diluted | $9.94 | $3.51 | $4.17 | $4.22 | $0.10 | $4.93 | $3.64 | $4.50 | $0.38 | $6.78 | ($2.65) | |
| Common Stock, Dividends, Per Share, Declared | $1.84 | $2.08 | $2.28 | $2.52 | $2.72 | $2.84 | $2.92 | $0.75 | $3.08 | $3.16 | — | |
| Weighted Average Number of Shares Outstanding, Basic | 1.3b | 1.3b | 1.3b | 1.3b | 1.3b | 1.3b | 1.3b | 1.2b | 1.2b | 1.2b | 1.2b | |
| Weighted Average Number of Shares Outstanding, Diluted | 1.4b | 1.3b | 1.3b | 1.3b | 1.3b | 1.3b | 1.3b | 1.3b | 1.3b | 1.3b | 1.2b | |
| Additional Financial Items | ||||||||||||
| Costs and Expenses | $12.8b | $12.0b | $13.9b | $18.2b | $20.6b | $17.4b | $20.0b | $19.5b | $27.1b | $19.4b | — | |
| Other (income) expense, net | $428.0m | $523.0m | $676.0m | $1.9b | ($1.4b) | ($639.0m) | ($581.0m) | $198.0m | ($6.0m) | ($798.0m) | ($13.0b) |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.